Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00697385 · ClinicalTrials.gov registry record · NA
The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders
A NA study of Hemophilia and Von Willebrand Disease, sponsored by Mary M. Gooley Hemophilia Center.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT00697385: Completed NA study of Hemophilia and Von Willebrand Disease, sponsored by Mary M. Gooley Hemophilia Center.
NCT00697385 is a NA study of Hemophilia and Von Willebrand Disease that has completed, run by Mary M. Gooley Hemophilia Center. The registered enrollment target is 13 participants, below the 409-participant average among 9 other Hemophilia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00697385, a NA study of Hemophilia and Von Willebrand Disease, has completed, sponsored by Mary M. Gooley Hemophilia Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The high percentage of failure using available non-surgical options to treat menorrhagia in women with bleeding disorders shows a continuing need for innovative treatments. This has led to development of this protocol in order to make available tranexamic acid as a potentially effective menorrhagia therapy option in women with an underlying bleeding disorder. We anticipate that Tranexamic Acid may be a beneficial choice for controlling menorrhagia in bleeding disorder patients.
Conditions Studied
Interventions
- DRUG Cyclokapron
Study Locations (1)
New York
- Mary M. Gooley Hemophilia Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2003-04 |
| Est. Completion | 2008-06 |
| Phase | NA |
What the finished NCT00697385 record still lists
NCT00697385 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 409-participant average among 9 other Hemophilia trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Hemophilia appearing as the primary indexed condition, and to 1 intervention - of which Cyclokapron is the first listed.
NCT00697385 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00697385 about?
NCT00697385 is a clinical study titled "The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders". The high percentage of failure using available non-surgical options to treat menorrhagia in women with bleeding disorders shows a continuing need for innovative treatments. This has led to development of this protocol in order to make available tranexamic acid as a potentially effective menorrhagia ...
What is the current status of trial NCT00697385?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2003-04. Estimated completion is 2008-06.
What conditions does trial NCT00697385 study?
This clinical trial studies the following conditions: Hemophilia, Von Willebrand Disease, Platelet Coagulation Disorders.
What interventions are being tested in trial NCT00697385?
The interventions under investigation include: Cyclokapron (DRUG).
Who is sponsoring clinical trial NCT00697385?
This trial is sponsored by Mary M. Gooley Hemophilia Center, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00697385 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemophilia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00697385's enrollment target sits among peer trials
13 10th of 9 the lowest of 9 other Hemophilia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hemophilia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Trial of Factor XIII (FXIII) Concentrate
COMPLETED · NA
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RECRUITING
-
Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study
RECRUITING · Early Phase 1
-
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
RECRUITING · Phase 3
-
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX
ACTIVE NOT RECRUITING · Phase 3
-
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia